Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population - Clinical Lymphoma, Myeloma and Leukemia
Improved long-term survival in multiple myeloma up to the age of 80 years | Leukemia
Blog Archives - Multiple Myeloma - Survival Rate Statistics by Hospital
Trends in overall survival and costs of multiple myeloma, 2000–2014 | Leukemia
Impact of Novel Therapies on Multiple Myeloma Survival– Current and Future Outcomes - Clinical Lymphoma, Myeloma and Leukemia
Cureus | Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients
Daratumumab, Lenalinomide, and Dexamethasone for Myeloma | NEJM Resident 360
Frontiers | Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes - Landgren - 2017 - Journal of Internal Medicine - Wiley Online Library
Retrospective analysis of 264 multiple myeloma patients
Overall survival (OS) in 253 patients with multiple myeloma... | Download Scientific Diagram
Myeloma survival statistics | Cancer Research UK
A Multiple Myeloma Roundtable: Treatment Trends and Recent Clinical Advances
Figure 1 from Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. | Semantic Scholar
Kaplan-Meier curves for overall survival for patients with genetic... | Download Scientific Diagram
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic he
Progression-free and overall survival for high-risk patients with relapsed or refractory multiple myeloma (RRMM) who received carfilzomib-based regimens
Overall survival of multiple myeloma based on clinical stage at... | Download Scientific Diagram
Disparities in Care and Outcomes
Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients | PLOS ONE
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
